• Wed news: Gilead HIV pipeline. Walgreens may go private. How Trump 2.0 will affect medtech. Lilly to offer Zepbound via Ro Telehealth. Pharma’s regulatory optimism. See more on our front page

A place to discuss your concerns

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 04, 2020 at 01:21: PM
We know many of you are concerned about your job security and/or about exposure to COVID-19 at work. Many of you are discussing these issues on your company boards. We thought you may want a place to discuss general concerns about these issues.

If your post is primarily political in nature, please post on our Political Discussions forum.
 
Last edited:






I think access will be limited geographically. Many thousands of practices and hospitals besides NYC area furloughed employees as there are no patients. I would envision sales force reductions. Nothing new, Pharmas been doing it last 2 decades. Virtual detail and less reps are the new model.
 






Our re-entry will be staggered, using combination of virtual and in-office meetings. We’ve been assured of no layoffs, but everyone is updating their LinkedIn profile during WFH.

Would love to hear from others regarding virtual selling: Are you doing virtual meetings with providers? If so, have they been valuable?
 






Top Bottom
Back
Quote